EF
RMD icon

Empowered Funds’s ResMed RMD Stock Holding History

Empowered Funds’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2M Buy
88,258
+69,030
+359% +$14.3M 0.09% 232
2026
Q1 		$4.32M Buy
+19,228
New +$4.79M 0.03% 704
2025
Q4 		– Sell
-16,033
Closed -$4.39M – 1718
2025
Q3 		$4.39M Buy
16,033
+3,290
+26% +$899K 0.04% 527
2025
Q2 		$3.29M Buy
12,743
+2,043
+19% +$487K 0.04% 600
2025
Q1 		$2.4M Sell
10,700
-1,410
-12% -$329K 0.03% 658
2024
Q4 		$2.77M Buy
12,110
+3,902
+48% +$940K 0.04% 584
2024
Q3 		$2M Buy
8,208
+6,072
+284% +$1.36M 0.03% 674
2024
Q2 		$409K Sell
2,136
-628
-23% -$127K 0.01% 1112
2024
Q1 		$547K Buy
2,764
+1,300
+89% +$238K 0.01% 1060
2023
Q4 		$252K Buy
+1,464
New +$225K 0.01% 1155
2023
Q3 		– Sell
-984
Closed -$215K – 1257
2023
Q2 		$215K Buy
+984
New +$219K 0.01% 1060
2020
Q3 		– Sell
-8,009
Closed -$1.54M – 146
2020
Q2 		$1.54M Buy
+8,009
New +$1.31M 0.6% 56

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Empowered Funds's RMD Position: Q2 2026 in Review

Empowered Funds increased its ResMed (RMD) stake by 359% in Q2 2026, buying an estimated $14.3M and bringing the position to 88,258 shares worth $17.2M. The position accounts for 0.09% of the portfolio, ranked #232.

Empowered Funds first reported a position in RMD in Q2 2020 and has held it in 12 quarters since. 885 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Empowered Funds held 88,258 shares of ResMed worth $17.2M as of Q2 2026.
  • Empowered Funds bought 69,030 ResMed shares in Q2 2026, an estimated $14.3M.
  • ResMed made up 0.09% of Empowered Funds's portfolio in Q2 2026, its #232 holding.
  • Empowered Funds first reported a position in ResMed in Q2 2020 and has held it in 12 quarters since.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.